山东大学学报 (医学版) ›› 2026, Vol. 64 ›› Issue (7): 28-34.doi: 10.6040/j.issn.1671-7554.0.2025.1179
张明祥1,2,吕琳2,林慧2,孙金鹏2,张道来1
ZHANG Mingxiang1,2, LYU Lin2, LIN Hui2, SUN Jinpeng2, ZHANG Daolai1
摘要: 目的 探讨神经酰胺C16∶0激活甲酰肽受体2(formyl peptide receptor 2, FPR2)调控棕色脂肪组织(brown adipose tissue, BAT)产热的下游关键基因及其分子机制。 方法 以小鼠BAT为研究对象,使用神经酰胺C16∶0 [10 mg/(kg·d)]和空载体连续3 d给小鼠进行腹腔注射,之后在4 ℃环境中暴露24 h。采用Western blotting和qPCR技术检测BAT中解偶联蛋白1(uncoupling protein 1, UCP1)的表达水平。利用转录组学测序技术进一步筛选神经酰胺C16∶0调控BAT产热的相关基因,并通过qPCR法对筛选的基因进行验证。 结果 神经酰胺C16∶0可以降低BAT中UCP1的mRNA表达水平[(0.608±0.066)vs.(1.001±0.033), F=3.879, P=0.017]和蛋白水平[(0.725±0.036)vs.(1.000±0.043), F=1.365, P=0.008];转录组学测序共筛选出909个差异表达基因(620个上调,289个下调)。GO和KEGG富集分析显示,神经酰胺C16∶0显著下调过氧化物酶体增殖物激活受体(peroxisome proliferators-activated receptor, PPAR)和叉头框蛋白O(forkhead box O, FOXO)信号通路,从中筛选出7个基因(SLC27A2、HMGCS2、EHHADH、PCK1、IRS2、SGK2、PLK3),在Sox2-CreER+/-Fpr2fl/fl小鼠中验证发现,其表达受神经酰胺C16∶0-FPR2轴特异性调控。 结论 神经酰胺C16∶0通过FPR2下调小鼠BAT中UCP1表达,其机制与PPAR信号通路和FOXO信号通路密切相关,通过调控SLC27A2、HMGCS2、EHHADH、PCK1、IRS2、SGK2和PLK3基因表达抑制BAT产热。
中图分类号:
| [1] | Yang J, Zhang H L, Parhat K, et al. Molecular imaging of brown adipose tissue mass[J]. Int J Mol Sci, 2021, 22(17): 9436. DOI:10.3390/ijms22179436 |
| [2] | 王腾威, 林慧, 张明祥, 等. P19激活GPR56的Gq通路促进米色脂肪棕色化[J]. 山东大学学报(医学版), 2024, 62(3): 20-27. Wang Tengwei, Lin Hui, Zhang Mingxiang, et al. P19 activates the Gq pathway of GPR56 to promote browning of beige adipose[J]. Journal of Shandong University(Health Science), 2024, 62(3): 20-27. |
| [3] | Bertholet A M, Natale A M, Bisignano P, et al. Mitochondrial uncouplers induce proton leak by activating AAC and UCP1[J]. Nature, 2022, 606(7912): 180-187. |
| [4] | Johnson J M, Peterlin A D, Balderas E, et al. Mitochondrial phosphatidylethanolamine modulates UCP1 to promote brown adipose thermogenesis[J]. Sci Adv, 2023, 9(8): eade7864. DOI:10.1126/sciadv.ade7864 |
| [5] | Lin H, Ma C S, Cai K, et al. Metabolic signaling of ceramides through the FPR2 receptor inhibits adipocyte thermogenesis[J]. Science, 2025, 388(6746): eado4188. DOI:10.1126/science.ado4188 |
| [6] | Summers S A, Chaurasia B, Holland W L. Metabolic messengers: ceramides[J]. Nat Metab, 2019, 1(11): 1051-1058. |
| [7] | Hannun Y A, Obeid L M. Principles of bioactive lipid signalling: lessons from sphingolipids[J]. Nat Rev Mol Cell Biol, 2008, 9(2): 139-150. |
| [8] | Choi R H, Tatum S M, Symons J D, et al. Ceramides and other sphingolipids as drivers of cardiovascular disease[J]. Nat Rev Cardiol, 2021, 18(10): 701-711. |
| [9] | Turpin-Nolan S M, Brüning J C. The role of ceramides in metabolic disorders: when size and localization matters[J]. Nat Rev Endocrinol, 2020, 16(4): 224-233. |
| [10] | Holland W L, Brozinick J T, Wang L P, et al. Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance[J]. Cell Metab, 2007, 5(3): 167-179. |
| [11] | 李本柏, 成晓亮, 王融, 等. 神经酰胺的检测方法及临床应用进展[J]. 中华检验医学杂志, 2024, 47(7): 827-832. Li Benbai, Cheng Xiaoliang, Wang Rong, et al. Progress in the detection methods and clinical applications of ceramides[J]. Chinese Journal of Laboratory Medicine, 2024, 47(7): 827-832. |
| [12] | Zhang S T, Lin H, Wang J L, et al. Sensing ceramides by CYSLTR2 and P2RY6 to aggravate atherosclerosis[J]. Nature, 2025, 641(8062): 476-485. |
| [13] | Zhang X Z, Zhang Y M, Wang P C, et al. Adipocyte hypoxia-inducible factor 2α suppresses atherosclerosis by promoting adipose ceramide catabolism[J]. Cell Metab, 2019, 30(5): 937-951. |
| [14] | Lefebvre P, Chinetti G, Fruchart J C, et al. Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasis[J]. J Clin Invest, 2006, 116(3): 571-580. |
| [15] | Pyper S R, Viswakarma N, Yu S T, et al. PPARalpha: energy combustion, hypolipidemia, inflammation and cancer[J]. Nucl Recept Signal, 2010, 8: e002. DOI:10.1621/nrs.08002 |
| [16] | Li Y K, Pan Y J, Zhao X D, et al. Peroxisome prolife-rator-activated receptors: a key link between lipid meta-bolism and cancer progression[J]. Clin Nutr, 2024, 43(2): 332-345. |
| [17] | Lee Y K, Sohn J H, Han J S, et al. Perilipin 3 deficiency stimulates thermogenic beige adipocytes through PPARα activation[J]. Diabetes, 2018, 67(5): 791-804. |
| [18] | Waldén T B, Petrovic N, Nedergaard J. PPARalpha does not suppress muscle-associated gene expression in brown adipocytes but does influence expression of factors that fingerprint the brown adipocyte[J]. Biochem Biophys Res Commun, 2010, 397(2): 146-151. |
| [19] | Guo Y Y, Li B Y, Xiao G, et al. Cdo1 promotes PPARγ-mediated adipose tissue lipolysis in male mice[J]. Nat Metab, 2022, 4(10): 1352-1368. |
| [20] | 张仙宏, 魏萌萌, 袁冬冬, 等. 转录因子FOXOs家族调控肿瘤生物学功能的研究进展[J]. 生理学报, 2022, 74(5): 843-855. Zhang Xianhong, Wei Mengmeng, Yuan Dongdong, et al. Research progress on the role of FOXOs family in cancer[J]. Acta Physiologica Sinica, 2022, 74(5): 843-855. |
| [21] | Lettieri Barbato D, Tatulli G, Aquilano K, et al. Mitochondrial Hormesis links nutrient restriction to improved metabolism in fat cell[J]. Aging, 2015, 7(10): 869-881. |
| [1] | 王腾威,林慧,张明祥,孙金鹏,张道来. P19激活GPR56的Gq通路促进米色脂肪棕色化[J]. 山东大学学报 (医学版), 2024, 62(3): 20-27. |
|
||